DIGITAL DRUG ASSIGNMENT
DEAD

Serial Number

98578560

Owner

GENOMATE HEALTH INC.

Attorney

SUDIP K. MITRA

Filing Date

May 31, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DIGITAL DRUG ASSIGNMENT Trademark

Serial Number: 98578560

DIGITAL DRUG ASSIGNMENT is a trademark filed by GENOMATE HEALTH INC. on May 31, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

GENOMATE HEALTH INC. (6 trademarks)

1 BROADWAY
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 31, 2024

Registration Date

Not Registered

Goods & Services

Health counseling; Medical clinic services; Medical services; Pharmaceutical advice; Telemedicine services; Health care services, namely, personalized therapy services and clinical decision support services; Consulting services in the field of health care to assist with biomedical and clinical decisions; medical diagnostic testing, monitoring and reporting services in personalized medicine; Health counseling

Biological research; Medical research; Scientific research; Research services in the field of genomic science; Technology advisory services related to genomic research; Scientific research in the field of genomics; Software as a service (SAAS) services featuring software used for the analysis of genomes, molecular diagnostic tests to predict treatment response and improve diagnostics in the medical, scientific and biological fields; Interactive web-based communication platform as a service for medical and biological data sharing, namely, disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Scientific research; Science and technology services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 2, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 2, 2025 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Dec 13, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Dec 13, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 13, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 13, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 13, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 13, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2024 NWOS
NEW APPLICATION ENTERED
May 31, 2024 NWAP